טוען...
Low-density lipoprotein cholesterol lowering treatment: the current approach
In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase inhibitor...
שמור ב:
| הוצא לאור ב: | Lipids Health Dis |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201678/ https://ncbi.nlm.nih.gov/pubmed/32375792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-020-01275-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|